. . . . . . . "[Given its track record in clinical use with limited toxicity, ZA holds promise as an 'unconventional' MMP-9 inhibitor for antiangiogenic therapy of cervical cancer and potentially for additional cancers and other diseases where MMP-9 expression by infiltrating macrophages is evident.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:39+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .